The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy

Recruiting · NCT06981026 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Olomouc

View the official record on ClinicalTrials.gov →

Prostate cancer

Interventions studied

Telemedicine-based prehabilitation and postoperative rehabilitation protocol, including physical activity monitoring, respiratory and postural training, and guidance via telehealth tools.

What this trial is about

The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.

Who can take part

Age range

40 Years to 80 Years

Sex

Male

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not applicable (e.g. observational or device study)

Study type

Interventional (participants receive a specific treatment)

Inclusion criteria

Biopsy-confirmed localized prostate cancer (ICD code C.61).
Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
No known urethral stricture or colostomy or chronic urinary catheterization.
No medical or current psychiatric disorders that precludes their participation in the study.
Status of the musculoskeletal system allowing physical exercise.
Urinary continent at baseline.
Has reliable internet and the skills/knowledge to use technologies use for the study.

Exclusion criteria

Other malignant tumors, except for benign skin carcinoma.
Active treatment for other oncological diagnoses.
Presence of preoperative urinary incontinence.
Diagnosed mental or cognitive disorders.
Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence.
Severe musculoskeletal disorders preventing active exercise
Inability to use required technologies

Where it is running

1 location listed.

Urology clinic, University hospital Olomouc - Olomouc, Czechia

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →